vs

Side-by-side financial comparison of Chime Financial, Inc. (CHYM) and CLARIVATE PLC (CLVT). Click either name above to swap in a different company.

CLARIVATE PLC is the larger business by last-quarter revenue ($585.5M vs $543.5M, roughly 1.1× Chime Financial, Inc.). CLARIVATE PLC runs the higher net margin — -6.9% vs -10.1%, a 3.2% gap on every dollar of revenue. On growth, Chime Financial, Inc. posted the faster year-over-year revenue change (28.8% vs -1.4%). CLARIVATE PLC produced more free cash flow last quarter ($78.9M vs $15.4M).

Chime Financial, Inc. is an American financial technology company based in San Francisco, California. It provides fee-free mobile banking services through two national banks, Stride Bank and The Bancorp Bank.

Clarivate Plc is a British-American publicly traded analytics company that operates a collection of subscription-based services, in the areas of bibliometrics and scientometrics; business and market intelligence, and competitive profiling for pharmacy and biotech, patents, and regulatory compliance; trademark protection, and domain and brand protection. Clarivate calculates the impact factor of scientific journals, using data from its Web of Science product family, that also includes services...

CHYM vs CLVT — Head-to-Head

Bigger by revenue
CLVT
CLVT
1.1× larger
CLVT
$585.5M
$543.5M
CHYM
Growing faster (revenue YoY)
CHYM
CHYM
+30.2% gap
CHYM
28.8%
-1.4%
CLVT
Higher net margin
CLVT
CLVT
3.2% more per $
CLVT
-6.9%
-10.1%
CHYM
More free cash flow
CLVT
CLVT
$63.5M more FCF
CLVT
$78.9M
$15.4M
CHYM

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
CHYM
CHYM
CLVT
CLVT
Revenue
$543.5M
$585.5M
Net Profit
$-54.7M
$-40.2M
Gross Margin
87.2%
67.2%
Operating Margin
-11.9%
5.2%
Net Margin
-10.1%
-6.9%
Revenue YoY
28.8%
-1.4%
Net Profit YoY
-148.4%
61.3%
EPS (diluted)
$-0.15
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHYM
CHYM
CLVT
CLVT
Q1 26
$585.5M
Q4 25
$617.0M
Q3 25
$543.5M
$623.1M
Q2 25
$528.1M
$621.4M
Q1 25
$593.7M
Q4 24
$663.0M
Q3 24
$421.9M
$622.2M
Q2 24
$384.2M
$650.3M
Net Profit
CHYM
CHYM
CLVT
CLVT
Q1 26
$-40.2M
Q4 25
$3.1M
Q3 25
$-54.7M
$-28.3M
Q2 25
$-923.4M
$-72.0M
Q1 25
$-103.9M
Q4 24
$-191.8M
Q3 24
$-22.0M
$-65.6M
Q2 24
$385.0K
$-304.3M
Gross Margin
CHYM
CHYM
CLVT
CLVT
Q1 26
67.2%
Q4 25
66.8%
Q3 25
87.2%
65.0%
Q2 25
87.3%
67.2%
Q1 25
65.1%
Q4 24
65.7%
Q3 24
87.3%
66.2%
Q2 24
86.9%
67.2%
Operating Margin
CHYM
CHYM
CLVT
CLVT
Q1 26
5.2%
Q4 25
6.7%
Q3 25
-11.9%
7.1%
Q2 25
-176.2%
1.1%
Q1 25
-3.5%
Q4 24
-9.4%
Q3 24
-7.3%
3.5%
Q2 24
-2.5%
-36.9%
Net Margin
CHYM
CHYM
CLVT
CLVT
Q1 26
-6.9%
Q4 25
0.5%
Q3 25
-10.1%
-4.5%
Q2 25
-174.8%
-11.6%
Q1 25
-17.5%
Q4 24
-28.9%
Q3 24
-5.2%
-10.5%
Q2 24
0.1%
-46.8%
EPS (diluted)
CHYM
CHYM
CLVT
CLVT
Q1 26
$-0.06
Q4 25
$0.00
Q3 25
$-0.15
$-0.04
Q2 25
$-7.29
$-0.11
Q1 25
$-0.15
Q4 24
$-0.27
Q3 24
$-0.34
$-0.09
Q2 24
$0.00
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHYM
CHYM
CLVT
CLVT
Cash + ST InvestmentsLiquidity on hand
$445.0M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$1.4B
$4.8B
Total Assets
$2.0B
$10.9B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHYM
CHYM
CLVT
CLVT
Q1 26
Q4 25
$329.2M
Q3 25
$445.0M
$318.7M
Q2 25
$868.3M
$362.6M
Q1 25
$354.0M
Q4 24
$295.2M
Q3 24
$270.8M
$388.5M
Q2 24
$295.4M
$376.4M
Total Debt
CHYM
CHYM
CLVT
CLVT
Q1 26
$4.3B
Q4 25
$4.3B
Q3 25
$4.4B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.6B
Q2 24
$4.6B
Stockholders' Equity
CHYM
CHYM
CLVT
CLVT
Q1 26
$4.8B
Q4 25
$4.8B
Q3 25
$1.4B
$4.9B
Q2 25
$1.4B
$5.0B
Q1 25
$5.0B
Q4 24
$5.1B
Q3 24
$-1.9B
$5.5B
Q2 24
$-1.9B
$5.6B
Total Assets
CHYM
CHYM
CLVT
CLVT
Q1 26
$10.9B
Q4 25
$11.1B
Q3 25
$2.0B
$11.2B
Q2 25
$1.9B
$11.4B
Q1 25
$11.5B
Q4 24
$11.5B
Q3 24
$12.0B
Q2 24
$12.1B
Debt / Equity
CHYM
CHYM
CLVT
CLVT
Q1 26
0.89×
Q4 25
0.89×
Q3 25
0.90×
Q2 25
0.90×
Q1 25
0.90×
Q4 24
0.88×
Q3 24
0.84×
Q2 24
0.83×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHYM
CHYM
CLVT
CLVT
Operating Cash FlowLast quarter
$17.5M
$134.7M
Free Cash FlowOCF − Capex
$15.4M
$78.9M
FCF MarginFCF / Revenue
2.8%
13.5%
Capex IntensityCapex / Revenue
0.4%
9.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$333.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHYM
CHYM
CLVT
CLVT
Q1 26
$134.7M
Q4 25
$159.9M
Q3 25
$17.5M
$181.1M
Q2 25
$2.7M
$116.3M
Q1 25
$171.2M
Q4 24
$141.3M
Q3 24
$202.9M
Q2 24
$126.2M
Free Cash Flow
CHYM
CHYM
CLVT
CLVT
Q1 26
$78.9M
Q4 25
$89.2M
Q3 25
$15.4M
$115.5M
Q2 25
$-888.0K
$50.3M
Q1 25
$110.3M
Q4 24
$59.1M
Q3 24
$126.3M
Q2 24
$60.3M
FCF Margin
CHYM
CHYM
CLVT
CLVT
Q1 26
13.5%
Q4 25
14.5%
Q3 25
2.8%
18.5%
Q2 25
-0.2%
8.1%
Q1 25
18.6%
Q4 24
8.9%
Q3 24
20.3%
Q2 24
9.3%
Capex Intensity
CHYM
CHYM
CLVT
CLVT
Q1 26
9.5%
Q4 25
11.5%
Q3 25
0.4%
10.5%
Q2 25
0.7%
10.6%
Q1 25
10.3%
Q4 24
12.4%
Q3 24
12.3%
Q2 24
10.1%
Cash Conversion
CHYM
CHYM
CLVT
CLVT
Q1 26
Q4 25
51.58×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHYM
CHYM

Payments Revenue$363.2M67%
Platform Related Revenue$180.4M33%

CLVT
CLVT

Subscription$397.5M68%
Re-occurring$108.6M19%
Transactional$79.4M14%

Related Comparisons